CTI BioPharma, Baxalta Complete Submission of NDA for Pacritinib for Unmet Medical Need In Myelofibrosis
January 05, 2016 at 04:15 AM EST
CTI BioPharma Corp.(NASDAQ: CTIC) and Baxalta Incorporated (Baxalta) (NYSE: BXLT) today announced the completion of the rolling ...
